Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.

Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.

To get the details: Click Here

[Close Window]
Medical Sales Jobs Websites - the best Medical Sales Jobs | Laboratory Sales Jobs | Medical Device Sales Jobs

Posts under ‘Medical Sales Jobs’

Auxilium Announces Appointments to Enhance Leadership Team

Andrew I. Koven Named Executive Vice President, Chief Administrative Officer and General Counsel Mark A. Glickman Named Senior Vice President, Sales MALVERN, Pa., Feb. 6, 2012 (HSMN NewsFeed) — Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ), a spe…
Biopharmaceuticals, Personnel
Auxilium Pharmaceuticals

ALung Technologies Raises $10 Million in Series B Financing

Funding to support continued commercialization of the Hemolung Respiratory Assist System PITTSBURGH–(Healthcare Sales & Marketing Network)–ALung Technologies, Inc., a big developer of advanced respiratory products, announced today that it has clos…
Devices, Venture Capital
ALung Technologies, Hemolung

Cardinal Health Statement Regarding Temporary Restraining Order to Avoid Disruption in Controlled Medicine Shipments From Florida

DUBLIN, Ohio, Feb. 3, 2012 (HSMN NewsFeed) — Today Cardinal Health was granted a temporary restraining order against the Drug Enforcement Administration’s (DEA) immediate suspension order of its Lakeland, Fla. DEA registration. U.S. District Court fo…
Biopharmaceuticals, Distribution
Cardinal Health

Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302

* Threshold to receive $25 million upfront, plus further potential milestones and royalties * Deal provides Threshold option to co-commercialize in the United States * Phase 3 trial in soft tissue sarcoma on-going and randomized Phase II trial in pat…
Biopharmaceuticals, Oncology
Threshold Pharmaceuticals, Merck KGaA, TH-302, soft tissue sarcoma

Caris Diagnostics Announces Name Change to Miraca Life Sciences

Company to Provide Same High-Quality Anatomic Clinical laboratory Services Under New Name TOKYO and IRVING, Texas, Feb. 3, 2012 –(HSMN NewsFeed) — Caris Diagnostics, specializing in academic-caliber anatomic clinical laboratory services, today announced a company name ch…
Diagnostics
Miraca Life Sciences, Caris Diagnostics

Prometheus Announces New Chief Commercial Officer

SAN DIEGO, Feb. THREE, 2012 (HSMN NewsFeed) — Prometheus Laboratories Inc., a specialty pharma and diagnostic company, today announced the appointment of Anthony J. Yost as Senior Vice President and Chief Commercial Officer. Tony joins Prometheus…
Diagnostics, Personnel
Prometheus Laboratories

Ronnie Andrews Joins Life Technologies as President, Medical Sciences

Leveraging 25-Plus Years Diagnostic Industry Experience, Andrews Will Shape Life Technologies Molecular Diagnostics Business CARLSBAD, Calif., Feb. 2, 2012 (HSMN NewsFeed) — Life Technologies Corporation (NASDAQ: LIFE ) today announced that Ronnie An…
Diagnostics, Personnel
Life Technologies

Spectranetics Announces Interim Results from German Study Treating Patients with Peripheral In-Stent Restenosis

Results Provide Basis for Landmark EXCITE ISR Trial Underway in United States COLORADO SPRINGS, Colo.–(Healthcare Revenue & Product management Network)– Spectranetics Corporation (Nasdaq:SPNC ) today announced six month interim results from the PATENT (Photo-Abl…
Devices, Interventional
Spectranetics, PATENT study, peripheral in-stent restenosis, laser atherectomy

Syneron Announces New Ground Breaking evolastin(TM) Procedure

One treatment procedure primed to propel facial aesthetic procedures forward with unique results and significant science IRVINE, Calif., Feb. 2, 2012 (HSMN NewsFeed) — Syneron Medical Ltd. (NASDAQ: ELOS ), www.syneron.com, the global leader in medica…
Devices, Dermatology
Syneron Clinical, evolastin procedure

Boston Scientific Announces First Implant and Market Launch of PROMUS Element(TM) Plus Stent System in Europe

Platinum chromium coronary stent with enhanced delivery system now available in Europe and other international countries NATICK, Mass., Feb. 1, 2012 (HSMN NewsFeed) — Boston Scientific Corporation (NYSE: BSX ) announces first patient use and European…
Devices, Interventional Cardiology
Boston Scientific, PROMUS Element, Platinum Chromium, drug eluting stent